ataxin2 modulator ProMIS Neurosciences

N/A

Report date: 2025/03/14 16:23:04

Base Information

Drug Nameataxin2 modulator ProMIS Neurosciences
Drug Alias Namemonoclonal antibody targeting ataxin 2 (ProMIS Neurosciences)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAtaxin-2 modulators
TargetsAtaxin-2
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProMIS Neurosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesProMIS Neurosciences Inc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A